49 Wealth Management LLC lifted its position in CME Group Inc. (NASDAQ:CME – Free Report) by 21.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,748 shares of the financial services provider’s stock after acquiring an additional 481 shares during the quarter. 49 Wealth Management LLC’s holdings in CME Group were worth $757,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Webster Bank N. A. boosted its position in CME Group by 206.9% in the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 60 shares during the last quarter. Highline Wealth Partners LLC raised its stake in shares of CME Group by 84.3% during the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 43 shares during the period. Trifecta Capital Advisors LLC boosted its holdings in shares of CME Group by 59.2% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after buying an additional 42 shares during the last quarter. Ransom Advisory Ltd purchased a new stake in CME Group during the first quarter worth about $31,000. Finally, Westside Investment Management Inc. raised its position in CME Group by 105.0% in the second quarter. Westside Investment Management Inc. now owns 123 shares of the financial services provider’s stock worth $34,000 after acquiring an additional 63 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.
CME Group Price Performance
Shares of CME stock opened at $276.50 on Monday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market cap of $99.71 billion, a P/E ratio of 26.79, a P/E/G ratio of 4.41 and a beta of 0.38. The business’s 50 day moving average price is $265.86 and its 200-day moving average price is $272.42. CME Group Inc. has a fifty-two week low of $222.56 and a fifty-two week high of $290.79.
CME Group Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th will be given a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend is Friday, December 12th. CME Group’s payout ratio is currently 48.45%.
Analysts Set New Price Targets
Several research firms have recently weighed in on CME. JPMorgan Chase & Co. increased their price target on CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a research note on Tuesday, October 14th. Barclays reduced their price target on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 8th. Raymond James Financial dropped their price target on CME Group from $309.00 to $307.00 and set an “outperform” rating for the company in a research report on Monday, October 13th. Oppenheimer lifted their target price on shares of CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research report on Thursday, July 24th. Finally, Citigroup raised shares of CME Group from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $275.00 to $300.00 in a report on Thursday, September 25th. Eight investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, CME Group presently has a consensus rating of “Hold” and an average price target of $286.06.
View Our Latest Analysis on CME
Insider Transactions at CME Group
In other news, General Counsel Jonathan L. Marcus sold 392 shares of the company’s stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the transaction, the general counsel owned 7,851 shares in the company, valued at approximately $2,056,962. This represents a 4.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director William R. Shepard bought 262 shares of the company’s stock in a transaction that occurred on Thursday, September 25th. The stock was bought at an average price of $265.19 per share, for a total transaction of $69,479.78. Following the acquisition, the director directly owned 258,459 shares of the company’s stock, valued at $68,540,742.21. The trade was a 0.10% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have sold 14,043 shares of company stock worth $3,791,486 over the last quarter. Corporate insiders own 0.30% of the company’s stock.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
- Five stocks we like better than CME Group
- 3 Dividend Kings To Consider
- 3 Big Earnings Misses: Is It Time to Buy the Dip?
- Investing in the High PE Growth Stocks
- Is Robinhood’s 11% Post-Earnings Fall a Buy-the-Dip Opportunity?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- AI Demand Is Coming—Is Microchip Technology Ready?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
